The determination of dielectric constants of mixtures used in the treatment of epilepsy and the encapsulation of phenytoin in a titania matrix

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 300, Issue 1-2 SPEC. ISS., 2007, Pages 99-105

  Lopez, T ^a,d   Quintana, P ^b   Ascencio, J ^c   Gonzalez, R D ^e  

^a UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^b DEPARTAMENTO DE FÍSICA APLICADA   (Mexico)

^c INSTITUTO MEXICANO DEL PETRÓLEO   (Mexico)

^d NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^e Tulane University   (United States)

Author keywords

Biocompatibility; Dielectric constants; Epilepsy; Polarity; Sol gel reservoir

Indexed keywords

ADSORPTION; BIOCOMPATIBILITY; DISEASES; ENCAPSULATION; PATIENT TREATMENT; PERMITTIVITY; SOL-GELS; TITANIUM;

EPILEPSY; PHENYTOIN; SOL GEL RESERVOIRS; STEREOTACTIC SURGERY; VALPROIC ACIDS;

DRUG PRODUCTS;

ANTICONVULSIVE AGENT; PHENYTOIN; TITANIUM DIOXIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BRAIN REGION; CHEMICAL COMPOSITION; CONTROLLED STUDY; DEVICE; DIELECTRIC CONSTANT; DIPOLE; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG STRUCTURE; ENCAPSULATION; EPILEPSY; IMMUNOHISTOCHEMISTRY; INFRARED RADIATION; MALE; NERVE CELL; NONHUMAN; POROSITY; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY; TEMPORAL LOBE;

EID: 34247097797     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2006.10.061     Document Type: Article

References (25)

1. Betq ArVcaa H., Sqheyla K.Y., Moghdamb A., Akalanb N., Atilla A., and Vncala H. Carbidopa/levodopa-loaded biodegradable microspheres: in vivo evaluation on experimental Parkinsonism in rats. J. Control. Release 102 (2005) 689-697
2. Shah S.P. Drug delivery to the central nervous system: a review. J. Pharm. Sci. 6 2 (2003) 252-273
3. Löscher W., and Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat. Rev.: Neurosci. 6 (2005) 591-602
4. Lage H. ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int. J. Antimicrob. Agents 22 (2003) 188-199
5. De Lange E.C. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv. Drug Deliv. Rev. 56 (2004) 1793-1809
6. Löscher W. Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol. Sci. 23 (2002) 113-118
7. Pardridge W.M. The blood-brain barrier: bottleneck in brain drug development. Neurorx 2 (2005) 3-14
8. Schinkel A.H. P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev. 36 (1999) 179-194
9. Sukhai M., and Piquette-Miller M. Regulation of the multidrug resistance genes by stress signals. J. Pharm. Pharm. Sci. 3 (2000) 268-280
10. Bauer B., Hartz A.M., Fricker G., and Miller D.S. Modulation of P-glycoprotein transport function at the blood-brain barrier. Exp. Biol. Med. (Maywood) 230 (2005) 118-127
11. Zhu H.J., and Liu G.Q. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism. Life Sci. 75 (2004) 1313-1322
12. Liu X.D., and Liu G.Q. P glycoprotein regulated transport of glutamate at blood brain barrier. Acta Pharmacol. Sin. 22 (2001) 111-116
13. Regina A. Multidrug resistance in brain tumors: roles of the blood-brain barrier. Cancer Metast. Rev. 20 (2001) 13-25
14. Tamargo R.J., and Brem H. Drug delivery to the central nervous system: a review. Neurosurg. Quart. 2 (1992) 259-279
15. Pitt C.G., Gratzl M.M., Kimmel G.L., Surles J., and Schindler A. Aliphatic polyesters. Part II. The degradation of poly(-lactide), poly(-caprolactone), and their copolymers in vivo. Biomaterials 2 (1981) 215-220
16. Spenlehauer G., Vert M., Benoit J.P., and Boddaert A. In vitro and in vivo degradation of poly(lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 10 (1989) 557-563
17. Mauduit J., and Vert M. Les polymères à base d'acides lactiques et glycolique et la délivrance contrôlée des principes actifs. STP Pharma Sci. 3 (1993) 197
18. Prior-Cabanillas, Quijada-Garrido I., Frutos G., and Barrales-Rienda J.M. Influence of the swelling history on the swelling kinetics of stimuli-responsive poly[(N-isopropylacrylamide)-co-(methacrylic acid)] hydrogels. Polymer 46 3 (2005) 685-693
19. Lowe T.L., Virtanen J., and Tenhu H. Interactions of drugs and spin probes with hydrophobically modified polyelectrolyte hydrogels based on N-isopropylacrylamide. Polymer 40 10 (1999) 2595-3260
20. T. Lopez, E. Ortiz, P. Quintana, R.D. Gonzalez, A nanostructured titania bioceramicimplantable device capable of drug delivery to the temporal lobe of the brain, Surf. Colloid Sci. A, in press.
21. Castro Lopez V., Hadgraft J., and Snowden M.J. The use of colloidal microgels as a (trans)dermal drug delivery system. Int. J. Pharm. 23 (2002) 137-147
22. Ascencio-Gutierez J.A., Perez-Martin L., Otazo Sanchez E., Castro M., Contreras-Pulido D., and Cisneros G.A. Afinidad 487 (2000) 180-184
23. Torres Garcia E., Canizal G., Ramirez-Verduzco L.F., Marietto-Guevara F., and Ascencio J.A. Appl. Phys. A 79 (2004) 2037-2041
24. Rosquete Pina G.A., Zorilla C., Subramanian V., Alatorre J.A., and Ascencio J.A. Appl. Phys. A 79 (2004) 1913-1919
25. Perdew J.P., and Wang Y. Phys. Rev. B 45 (1992) 13244-13249